EUVIMED · CrossrefZeitschrift
The Journal of Community and Supportive Oncology
ISSN 2330-7749 · Frontline Medical Communications, Inc.
Neueste Artikel
Mindfulness-based cancer recovery in survivors recovering from chemotherapy and radiation
Hereditary breast and ovarian cancer: risk assessment in minority women and provider knowledge gaps
A qualitative exploration of supports and unmet needs of diverse young women with breast cancer
Inflammatory metastatic breast cancer with gallbladder metastasis: an incidental finding
Impact of a telehealth intervention on quality of life and symptom distress in patients with head and neck cancer
A feasibility study of dignity therapy in patients with stage IV colorectal cancer actively receiving second-line chemotherapy
Chemotherapy-induced peripheral neuropathy and impact on quality of life 6 months after treatment with chemotherapy
Patient and provider concordance on symptoms during the oncology outpatient clinic visit
Onco-bracketology? March Madness meets today’s practice
Bosutinib finds its place in the CML treatment paradigm
Digital acrometastasis: an unusual first presentation of an occult lung cancer
With enzalutamide for prostate cancer, it may all depend on the tumor’s AR profile
Levamisole contamination of cocaine resulting in neutropenia and thrombovasculopathy: a report from the Southern Network on Adverse Reactions (SONAR)
Nab-paclitaxel is a valuable NSCLC therapy option
Other therapy options may relegate omacetaxine to last-line choice for chronic or accelerated phase CML
From ASCO 2013, a line-up of possible practice changers
Use of the JAK1/JAK2 inhibitor ruxolitinib in the treatment of patients with myelofibrosis
Dawn of a new era: targeting the B-cell receptor signaling pathway to conquer B-cell lymphomas
Unexpectedly good results, and no chemotherapy required
Quality versus queasy: neurokinin 1 receptor antagonist use in moderately emetogenic chemotherapy
A look ahead for 2014
Afatinib approval for NSCLC brings EGFR TKI story full circle
Afatinib in metastatic NSCLC with mutations
Vitamin D deficiency in the oncology setting
Current options and future directions in the systemic treatment of metastatic melanoma
Biomarker testing for treatment of metastatic colorectal cancer: role of the pathologist in community practice
A ‘double-hit’ bone marrow rare co-occurrence of 2 different pathologies
Synthetic lethality: beating cancer at its own game
'I'm going to live forever': the guarantee-time bias
Understanding the experience of living with non–small-cell lung cancer (NSCLC): a qualitative study
EUVIMED